Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter November 29, 2016

Evaluation of an automated commercial ELISA method for calprotectin determination in pleural fluid

  • Lorena Vázquez-Iglesias , Pedro Casado-Rey , Maribel Botana-Rial , María Amalia Andrade-Olivié , Francisco Javier Rodriguez-Berrocal , María Páez de la Cadena and Alberto Fernández-Villar EMAIL logo

Acknowledgments

Special thanks are given to M. del Pozo for her technical assistance. The authors would like to thank Dr. L. De Chiara for reviewing the English grammar.

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: This research was supported by Research Intensification activity from the Fondo de Investigación Sanitaria (FIS) of the Instituto de Salud Carlos III (PI13/01538) and Xunta de Galicia (CN/2014) and FEDER founding. L.V. was supported by Fundación Biomédica Galicia Sur.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Heffner JE. Diagnosis and management of malignant pleural effusion. Respirology 2008;13:5–20.10.1111/j.1440-1843.2007.01154.xSearch in Google Scholar

2. Alemán C, Sánchez L, Alegre J, Ruiz E, Vázquez A, Soriano T, et al. Differentiating between malignant and idiopathic pleural effusions: the value of diagnostic procedures. QJM 2007;100:351–9.10.1093/qjmed/hcm032Search in Google Scholar

3. Hooper C, Lee YC, Maskell N. Investigation of a unilateral pleural effusion in adults: British Thoracic Society Pleural Disease Guideline. Thorax 2010;65(Suppl 2):ii4–17.10.1136/thx.2010.136978Search in Google Scholar

4. Villena V, Ferrer J, Hernández L, de Pablo A, Pérez E, Rodríguez F, et al. SEPAR. Diagnosis and treatment of pleural effusion. Arch Bronconeumol 2006;42:349–72.10.1016/S1579-2129(06)60545-4Search in Google Scholar

5. Sánchez-Otero N, Blanco-Prieto S, Páez de la Cadena M, Vázquez-Iglesias L, Fernández-Villar A, Botana-Rial MI, et al. Calprotectin: a novel biomarker for the diagnosis of pleural effusion. Br J Cancer 2012;107:1876–72.10.1038/bjc.2012.478Search in Google Scholar PubMed PubMed Central

6. Clinical and Laboratory Standards Institute (CLSI). User Verification of Performance for Precision and Trueness; Approved Guideline–Second Edition. CLSI document EP15-A2 (ISBN 1-56238-574-7). Wayne, Pennsylvania, USA, 2005.Search in Google Scholar

7. Canalias F, Boned B, Esteve S, Gella FJ, González de la Presa B, Izquierdo S, et al. Estudio de la precisión de los procedimientos de medida en el laboratorio clínico. Documento de la SEQC. Comisión de metrología. Quim Clin 2014;8:15–20.Search in Google Scholar

8. European Medicine Agency. Guideline on Bioanalytical Method Validation. EMA, Committee for Medicinal Products for Human Use (CHMP), London, UK, 2011.Search in Google Scholar

9. Davidson B, Stavnes HT, Førsund M, Berner A, Staff AC. CD105 (Endoglin) expression in breast carcinoma effusions is a marker of poor survival. Breast 2010;19:493–8.10.1016/j.breast.2010.05.013Search in Google Scholar PubMed

10. Ødegaard E, Davidson B, Engh V, Onsrud M, Staff AC. Assessment of endoglin and calprotectin as potential biomarkers in ovarian carcinoma and borderline tumors of the ovary. Am J Obstet Gynecol 2008;199:533–8.10.1016/j.ajog.2008.04.004Search in Google Scholar PubMed

11. Lutz P, Pfarr K, Nischalke HD, Krämer B, Goeser F, Glässner A, et al. The ratio of calprotectin to total protein as a diagnostic and prognostic marker for spontaneous bacterial peritonitis in patients with liver cirrhosis and ascites. Clin Chem Lab Med 2015;53:2031–9.10.1515/cclm-2015-0284Search in Google Scholar PubMed


Supplemental Material:

The online version of this article (DOI: https://doi.org/10.1515/cclm-2016-0884) offers supplementary material, available to authorized users.


Received: 2016-10-5
Accepted: 2016-11-3
Published Online: 2016-11-29
Published in Print: 2017-7-26

©2017 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 29.3.2024 from https://www.degruyter.com/document/doi/10.1515/cclm-2016-0884/html
Scroll to top button